We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RPHM market cap is 57.63M. The company's latest EPS is USD -2.3231 and P/E is -0.74.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.84M | -14.56M | -16.12M | -21.04M | -20.89M |
| Net Income | -13.01M | -13.6M | -15.11M | -19.53M | -19.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.47M | -19.55M | -39.82M | -53.85M | -83.05M |
| Net Income | -12.44M | -19.47M | -39.77M | -51.96M | -77.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 122.5M | 108.18M | 98.87M | 148.04M | 130.39M |
| Total Liabilities | 10.46M | 8.21M | 11.78M | 15.51M | 15.44M |
| Total Equity | 112.05M | 99.97M | 87.08M | 132.53M | 114.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.51M | 55.22M | 154.02M | 108.18M | 107.44M |
| Total Liabilities | 2.98M | 4.62M | 6.81M | 8.21M | 18.83M |
| Total Equity | -23.13M | -42.12M | 147.21M | 99.97M | 88.61M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31.75M | -47.36M | -9.05M | -25.16M | -43.93M |
| Investing | -30.93M | -57.84M | 18.51M | -50.5M | -29.25M |
| Financing | 146k | 471k | 1.01M | 64.82M | 64.99M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.51M | -18.54M | -37.98M | -47.36M | -63.68M |
| Investing | -7.24M | 7.38M | -23.38M | -57.84M | 10.52M |
| Financing | 24.99M | 47.27M | 132.41M | 471k | 60.87M |
| Market Cap | 57.63M |
| Price to Earnings Ratio | -0.74 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.09 |
| Price to Book Ratio | 0.65 |
| Dividend Yield | - |
| Shares Outstanding | 33.31M |
| Average Volume (1 week) | 121.5k |
| Average Volume (1 Month) | 108.27k |
| 52 Week Change | -83.48% |
| 52 Week High | 10.74 |
| 52 Week Low | 0.9801 |
| Spread (Intraday) | 0.11 (6.08%) |
| Company Name | Reneo Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://reneopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
